2Horl WH. The clinical consequences of secondary hyperparathyroidism:focus on clinical outcomes. Nephrol Dial Transplant, 2004, 19 Suppl 5:V2-8
3Lin CL, Hung CC, Yang CT, et al. Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients. Ren Fail, 2004, 26(3):289-95
4Brancaccio D, Cozzolino M, Gallieni M. Hyperparathyroidism andanemia in uremic subjects: a combined therapeutic approach.J AmSoc Nephrol, 2004, 15 Suppl 1:S21-4
5Lee CT, Chou FF, Chang HW, et al. Effects of parathyroidec tomy on iron homeostasis and erythropoiesis in hemodialysis patients with severe hyperparathyroidism. Blood Purif, 2003,21(6):369-75
6Drueke TB, Eckardt KU. Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients. Nephrol Dial Transplant, 2002, 17 Suppl 5:28-31
7Yasunaga C, Matsuo K, Yanagida T, et al. Early effects of parathyroidectomy on erythropoietin production in secondary hyperparathyroidism. Am J Surg, 2002, 183(2):199-204
8Coen G, Calabria S, Bellinghieri G, et al. Parathyroidectomy in chronic renal failure: short and long term results on parathyroid function, blood pressure and anemia. Nephron,2001,88(2):149-55
9Tilman Druoke. Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant, 2001,16 [suppl7]:25-28
10Falko JM, Guy JT, Smith RE, et al. Primary hyperparathyroid ism and anemia. Arch Intern Med, 1976, 136:887-889
